Related Experiment Video
Updated: May 2, 2026

Design and Development of a Model to Study the Effect of Supplemental Oxygen on the Cystic Fibrosis Airway Microbiome
Published on: August 3, 2021
Nitric oxide production by polymorphonuclear leucocytes in infected cystic fibrosis sputum consumes oxygen
M Kolpen1, T Bjarnsholt, C Moser
1Department of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark; Department of International Health, Immunology and Microbiology, Faculty of Health Sciences, University of Copenhagen, Helsingør, Denmark.
Abstract:
Chronic Pseudomonas aeruginosa lung infection in cystic fibrosis (CF) patients is characterized by persisting mucoid biofilms in hypoxic endobronchial mucus. These biofilms are surrounded by numerous polymorphonuclear leucocytes (PMNs), which consume a major part of present molecular oxygen (O(2)) due to production of superoxide (O(2)(-)). In this study, we show that the PMNs also consume O(2) for production of nitric oxide (NO) by the nitric oxide synthases (NOS) in the infected endobronchial mucus. Fresh expectorated sputum samples (n = 28) from chronically infected CF patients (n = 22) were analysed by quantifying and visualizing the NO production. NO production was detected by optode measurements combined with fluorescence microscopy, flow cytometry and spectrophotometry. Inhibition of nitric oxide synthases (NOS) with N(G) -monomethyl-L-arginine (L-NMMA) resulted in reduced O(2) consumption (P < 0·0008, n = 8) and a lower fraction of cells with fluorescence from the NO-indicator 4-amino-5-methylamino-2',7'-difluorofluorescein diacetate (DAF-FM) (P < 0·002, n = 8). PMNs stained with DAF-FM and the superoxide indicator hydroethidine (HE) and host cells with inducible NOS (iNOS) were identified in the sputum. In addition, the production of the stable end-products of NO in CF sputum was correlated with the concentration of PMNs; NO(3)(-) (P < 0·04, r = 0·66, n = 10) and NO(2)(-) (P< 0·006, r = 0·78, n = 11). The present study suggests that besides consumption of O(2) for production of reactive oxygen species, the PMNs in CF sputum also consume O(2) for production of NO.
Insights
Polymorphonuclear leukocytes (PMNs) in cystic fibrosis (CF) lung infections consume oxygen not only for superoxide production but also for nitric oxide (NO) generation. This finding reveals a dual role for PMNs in CF airway inflammation.
Area of Science:
- Pulmonary Medicine
- Immunology
- Microbiology
Background:
- Chronic Pseudomonas aeruginosa infection in cystic fibrosis (CF) patients involves mucoid biofilms in hypoxic mucus.
- These biofilms are associated with polymorphonuclear leukocytes (PMNs) that consume oxygen (O(2)) to produce superoxide (O(2)(-)).
Purpose of the Study:
- To investigate whether PMNs in CF sputum also consume O(2) for nitric oxide (NO) production.
- To quantify and visualize NO production in CF sputum and its correlation with PMN concentration.
Main Methods:
- Analysis of sputum samples from CF patients using optode measurements, fluorescence microscopy, flow cytometry, and spectrophotometry.
- Quantification of NO production and its inhibition using nitric oxide synthases (NOS) inhibitor N(G)-monomethyl-L-arginine (L-NMMA).
- Identification of PMNs and host cells expressing inducible NOS (iNOS) using specific fluorescent indicators.
Main Results:
- PMNs in CF sputum consume O(2) for NO production via NOS.
- Inhibition of NOS reduced O(2) consumption and NO production.
- NO production correlated positively with PMN concentration in CF sputum.
Conclusions:
- PMNs in CF sputum contribute to airway inflammation through both superoxide and NO production.
- This dual oxygen consumption by PMNs has implications for the understanding and treatment of CF lung infections.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Cystic Fibrosis: Management
Sinus disease and chronic...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Nitric Oxide Signaling Pathway
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

